$18.67
0.422.3%
Last update: Nov 9, 4:00 PM
City Therapeutics Inc
CTYNASDAQ
The average analyst price target for City Therapeutics is $34, 82.1% above the current price. The one analyst covering it rates it Buy. The latest change came on Nov 10, 2026, when Stifel initiated coverage of City Therapeutics with a Buy rating and a $34 price target.
Price Target Range — 1 Quarters
Analyst Consensus — 1 Analysts
Rating Trend — Last 9 Months
